FindTrial
Sign In

Efficacy of renal biomarkers in patients with decompensated cirrhosis

A study for the establishment of Serum and Urine Markers for the gloMerular function and renal tubular injury based Algorithm for the differentiation of type of Renal dYsfunction and for prognosis in patients with decompensated cirrhosis (SUMMARY study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004334
Enrollment
400
Registered
2019-10-16
Start date
2016-11-11
Completion date
Unknown
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea University Anam Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The hospitalized patients, over 20 years old, with cirrhosis and Child Pugh class B or C. Liver cirrhosis is diagnosed based on clinical, biochemical, radiologic and endoscopic images.

Exclusion criteria

Exclusion criteria: The patients with incurable malignancy, chronic renal parenchymal disease, and urinary tract infection or urinary tract obstruction. The patients got renal replacement therapy at enrollment The patients with history of liver or kidney transplantation The patients denied the current study

Design outcomes

Primary

MeasureTime frame
The development of acute kidney injury;Mortality—

Secondary

MeasureTime frame
The type of acute kidney injury in patients accompanied with that at enrollment—

Countries

Korea, Republic of

Contacts

Public ContactTaeHyung Kim

Korea University Anam Hospital

lacid81@gmail.com+82-2-920-6566

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026